The Circulatory System in Liver Disease.

Area of Science:

• Hepatology
• Cardiology
• Critical Care Medicine

Background:

• Cirrhotic liver architecture is altered by structural and vascular changes.
• Portal hypertension is linked to a hyperdynamic circulatory syndrome characterized by increased cardiac output and heart rate, and decreased systemic vascular resistance.
• Vasoactive substances reduce mesenteric arterial resistance, causing sodium and water retention, leading to ascites.

Purpose of the Study:

• To outline the hemodynamic alterations in cirrhotic liver disease.
• To explain the pathophysiology of ascites formation in portal hypertension.
• To emphasize the role of invasive hemodynamic monitoring in managing acute cardiac dysfunction in these patients.

Main Methods:

• Review of pathophysiology of cirrhotic liver disease and portal hypertension.
• Discussion of the hyperdynamic circulatory syndrome.
• Emphasis on the clinical management using invasive hemodynamic monitoring.

Main Results:

• Distorted liver architecture and portal hypertension are key features of cirrhosis.
• Hyperdynamic circulation and reduced systemic vascular resistance are characteristic.
• Vasoactive substances drive mesenteric arterial resistance reduction, leading to fluid retention and ascites.

Conclusions:

• Management of cirrhotic patients with cardiac dysfunction requires understanding hemodynamic changes.
• Invasive hemodynamic monitoring is crucial for guiding fluid and vasopressor therapy.
• Addressing the hyperdynamic state is essential for preventing and managing ascites.